Veracyte Announces Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Veracyte (VCYT) Misses Q3 EPS by 26c, Offers Guidance
November 7, 2023 4:19 PM ESTVeracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.41), $0.26 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $90.1 million versus the consensus estimate of $84.36 million.
GUIDANCE:
Veracyte sees FY2023 revenue of $352-354 million, versus the consensus of $347... More
